| Patent Number |
Title Of Patent |
Date Issued |
| 8025883 |
Antagonists and methods for inhibiting angiogenesis |
September 27, 2011 |
| The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen but not to native triple helical forms of the collagen. Antagonists of the invention can target, for example, denatured |
| 7345151 |
Antagonists specific for denatured collagen and methods of using same |
March 18, 2008 |
| The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen but not to native triple helical forms of the collagen. Antagonists of the invention can target, for example, denatured |
| 7122635 |
Method and composition for angiogenesis inhibition |
October 17, 2006 |
| The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen but not to native triple helical forms of the collagen. Antagonists of the invention can target, for example, denatured |
| 6500924 |
Methods and compositions useful for inhibition of angiogenesis |
December 31, 2002 |
| The present invention describes methods for inhibition of angiogenesis in tissues using vitronectin .alpha..sub.v.beta..sub.3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases using therapeutic compositions containing .a |
